217 related articles for article (PubMed ID: 33544833)
21. Pitfalls in early biochemical evaluation after transsphenoidal surgery in patients with acromegaly.
Nishioka H; Fukuhara N; Yamaguchi-Okada M; Takeshita A; Takeuchi Y; Yamada S
Endocr J; 2017 Nov; 64(11):1073-1078. PubMed ID: 28835593
[TBL] [Abstract][Full Text] [Related]
22. Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients.
Shimon I; Cohen ZR; Ram Z; Hadani M
Neurosurgery; 2001 Jun; 48(6):1239-43; discussion 1244-5. PubMed ID: 11383725
[TBL] [Abstract][Full Text] [Related]
23. Low insulin resistance after surgery predicts poor GH suppression one year after complete resection for acromegaly: a retrospective study.
Edo N; Morita K; Suzuki H; Takeshita A; Miyakawa M; Fukuhara N; Nishioka H; Yamada S; Takeuchi Y
Endocr J; 2016 May; 63(5):469-77. PubMed ID: 26949262
[TBL] [Abstract][Full Text] [Related]
24. Transsphenoidal surgery for growth hormone-secreting pituitary adenomas in 130 patients.
Shirvani M; Motiei-Langroudi R
World Neurosurg; 2014 Jan; 81(1):125-30. PubMed ID: 23313263
[TBL] [Abstract][Full Text] [Related]
25. Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly.
Freda PU; Wardlaw SL; Post KD
J Neurosurg; 1998 Sep; 89(3):353-8. PubMed ID: 9724106
[TBL] [Abstract][Full Text] [Related]
26. Results of endoscopic transsphenoidal pituitary surgery in 40 patients with a growth hormone-secreting macroadenoma.
Wagenmakers MA; Netea-Maier RT; van Lindert EJ; Pieters GF; Grotenhuis AJ; Hermus AR
Acta Neurochir (Wien); 2011 Jul; 153(7):1391-9. PubMed ID: 21347581
[TBL] [Abstract][Full Text] [Related]
27. Stereotactic radiosurgery for acromegaly.
Lee CC; Vance ML; Xu Z; Yen CP; Schlesinger D; Dodson B; Sheehan J
J Clin Endocrinol Metab; 2014 Apr; 99(4):1273-81. PubMed ID: 24471574
[TBL] [Abstract][Full Text] [Related]
28. A single-center experience of transsphenoidal endoscopic surgery for acromegaly in 73 patients: results and predictive factors for remission.
Unal TC; Aydoseli A; Ozgen U; Dolas I; Sabanci PA; Aras Y; Ozturk M; Ozata MS; Gul N; Kubat Uzum A; Mutlu U; Bilgic B; Saka E; Yarman S; Sencer A
Br J Neurosurg; 2024 Jun; 38(3):648-653. PubMed ID: 34241568
[TBL] [Abstract][Full Text] [Related]
29. The common consensus criteria have high predictive values for long-term postoperative acromegaly remission.
Kristof RA; Grote A; Redel L; Neuloh G; Klingmüller D; Schramm J
Acta Neurochir (Wien); 2011 Jan; 153(1):19-25. PubMed ID: 20845050
[TBL] [Abstract][Full Text] [Related]
30. Intraoperative magnetic resonance imaging-assisted transsphenoidal pituitary surgery in patients with acromegaly.
Bellut D; Hlavica M; Schmid C; Bernays RL
Neurosurg Focus; 2010 Oct; 29(4):E9. PubMed ID: 20887134
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of transsphenoidal surgery in achieving biochemical cure of growth hormone-secreting pituitary adenomas among patients with cavernous sinus invasion: a systematic review and meta-analysis.
Briceno V; Zaidi HA; Doucette JA; Onomichi KB; Alreshidi A; Mekary RA; Smith TR
Neurol Res; 2017 May; 39(5):387-398. PubMed ID: 28301972
[TBL] [Abstract][Full Text] [Related]
32. Predictors of surgical outcome and early criteria of remission in acromegaly.
Antunes X; Ventura N; Camilo GB; Wildemberg LE; Guasti A; Pereira PJM; Camacho AHS; Chimelli L; Niemeyer P; Gadelha MR; Kasuki L
Endocrine; 2018 Jun; 60(3):415-422. PubMed ID: 29626274
[TBL] [Abstract][Full Text] [Related]
33. [Outcome of surgical treatment for acromegaly performed by a single neurosurgeon and cumulative meta-analysis].
Boeving A; Borba LA; Rodrigues AM; Orichowski EB; Paz Filho GJ; Santos CM; Boguszewski CL
Arq Bras Endocrinol Metabol; 2006 Oct; 50(5):884-92. PubMed ID: 17160212
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and complications of neurosurgical treatment of acromegaly.
Krzentowska-Korek A; Gołkowski F; Bałdys-Waligórska A; Hubalewska-Dydejczyk A
Pituitary; 2011 Jun; 14(2):157-62. PubMed ID: 21107739
[TBL] [Abstract][Full Text] [Related]
35. Revisiting the Role of Insulin-like Growth Factor-1 Measurement After Surgical Treatment of Acromegaly.
Jung IH; Choi S; Ku CR; Lee SG; Lee EJ; Kim SH; Kim EH
J Clin Endocrinol Metab; 2021 Jun; 106(7):e2589-e2599. PubMed ID: 33738470
[TBL] [Abstract][Full Text] [Related]
36. HIGH-PRECISION CONFORMAL FRACTIONATED RADIOTHERAPY IS EFFECTIVE IN ACHIEVING REMISSION IN PATIENTS WITH ACROMEGALY AFTER FAILED TRANSSPHENOIDAL SURGERY.
Patt H; Jalali R; Yerawar C; Khare S; Gupta T; Goel A; Lila A; Bandgar T; Shah NS
Endocr Pract; 2016 Feb; 22(2):162-72. PubMed ID: 26492545
[TBL] [Abstract][Full Text] [Related]
37. Transsphenoidal surgery for acromegaly in wales: results based on stringent criteria of remission.
De P; Rees DA; Davies N; John R; Neal J; Mills RG; Vafidis J; Davies JS; Scanlon MF
J Clin Endocrinol Metab; 2003 Aug; 88(8):3567-72. PubMed ID: 12915637
[TBL] [Abstract][Full Text] [Related]
38. Final Outcome in Growth Hormone-Secreting Adenomas After Combination of Maximal Tumor Resection and Medical Treatment.
Torres A; Sanmillan JL; Lau R; Gabarros A
World Neurosurg; 2021 Oct; 154():e292-e301. PubMed ID: 34252630
[TBL] [Abstract][Full Text] [Related]
39. Outcome of surgical intrasellar growth hormone tumor performed by a pituitary specialist surgeon in a developing country.
Gondim JA; Ferraz T; Mota I; Studart D; Almeida JP; Gomes E; Schops M
Surg Neurol; 2009 Jul; 72(1):15-9; discussion 19. PubMed ID: 18440607
[TBL] [Abstract][Full Text] [Related]
40. Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes.
Nishioka H; Fukuhara N; Horiguchi K; Yamada S
J Neurosurg; 2014 Sep; 121(3):505-10. PubMed ID: 25014437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
